SecProbe Assistant
Ask questions like "How many comment letters were addressed to American Airlines in the past year?" or "Show me the latest company responses for Tesla."
Ask the Intelligence Terminal
Live dataset Q&ACorrespondence Library Search
Search the filing library by ticker, then explore SEC Comment Letters and Company Responses across the full dataset.
Last 10 Correspondence Filings
View All
Window
Filing Type
Urgency
| Date | Type | Company | Sentiment | Urgency | Open |
|---|---|---|---|---|---|
| Apr. 29, 2026 | SEC Comment Letter | STSFF SmartStop Self Storage REIT, Inc. (SMA) (CIK 0001585389) | Neutral/Informational | Low | Read Filing |
| Apr. 28, 2026 | Company Response | ENVB Enveric Biosciences, Inc. | Neutral/Informational | Moderate | Read Filing |
| Apr. 28, 2026 | Company Response | NITO Nexentis Technologies Inc. (NXTS) (CIK 0001789192) | Neutral/Informational | Moderate | Read Filing |
| Apr. 28, 2026 | Company Response | OPTX SYNTEC OPTICS HOLDINGS, INC. | Neutral/Informational | Moderate | Read Filing |
| Apr. 28, 2026 | SEC Comment Letter | LEGT Legato Merger Corp. III | Neutral/Informational | Low | Read Filing |
| Apr. 27, 2026 | SEC Comment Letter | ENVB Enveric Biosciences, Inc. | Concern from SEC | Moderate | Read Filing |
| Apr. 27, 2026 | SEC Comment Letter | BATL BATTALION OIL CORP | Concern from SEC | Moderate | Read Filing |
| Apr. 27, 2026 | SEC Comment Letter | CVKD Cadrenal Therapeutics, Inc. | Neutral/Informational | Low | Read Filing |
| Apr. 27, 2026 | SEC Comment Letter | APRE Aprea Therapeutics, Inc. | Neutral/Informational | Low | Read Filing |
| Apr. 27, 2026 | Company Response | CVKD Cadrenal Therapeutics, Inc. | Neutral/Informational | Moderate | Read Filing |
Most Active SEC Correspondence
View All
Window
Sector
Industry
| Ticker | Company | Total | SEC Comment Letter | Company Response | Latest Filing | View Correspondence |
|---|---|---|---|---|---|---|
| PPCB | Propanc Biopharma, Inc. | 12 | 2 | 10 | April 16, 2026 | View Correspondence |
| YCY | AA Mission Acquisition Corp. II | 12 | 3 | 9 | Sept. 29, 2025 | View Correspondence |
| REED | REED'S, INC. | 11 | 3 | 8 | Dec. 2, 2025 | View Correspondence |
| KTTA | Pasithea Therapeutics Corp. | 11 | 1 | 10 | Nov. 26, 2025 | View Correspondence |
| FRMI | Fermi Inc. | 11 | 5 | 6 | Sept. 30, 2025 | View Correspondence |
| GEMI | Gemini Space Station, Inc. | 11 | 4 | 7 | Sept. 10, 2025 | View Correspondence |
| SKYX | SKYX Platforms Corp. | 10 | 3 | 7 | March 31, 2026 | View Correspondence |
| PFSA | Profusa, Inc. | 10 | 4 | 6 | Feb. 17, 2026 | View Correspondence |
| RUBI | Rubico Inc. | 10 | 4 | 6 | Oct. 8, 2025 | View Correspondence |
| SUIG | SUI Group Holdings Ltd. | 10 | 4 | 6 | Sept. 29, 2025 | View Correspondence |
SEC Letters Issued By Sector
Window
| # | Sector | SEC Upload Letters |
|---|---|---|
| 1 | Healthcare | 387 |
| 2 | Financial Services | 192 |
| 3 | Technology | 176 |
| 4 | Consumer | 91 |
| 5 | Energy | 90 |
Regulatory Attention By Sector
Window
| # | Sector | Companies With Letters | Total Companies | Exposure Rate |
|---|---|---|---|---|
| 1 | Healthcare | 274 | 1231 | 22.3% |
| 2 | Energy | 55 | 365 | 15.1% |
| 3 | Technology | 134 | 984 | 13.6% |
| 4 | Financial Services | 124 | 1050 | 11.8% |
| 5 | Consumer | 70 | 727 | 9.6% |
SEC Letters Issued By Industry
Window
| # | Industry | SEC Upload Letters |
|---|---|---|
| 1 | Biotechnology | 287 |
| 2 | Software & IT Services | 162 |
| 3 | Asset Management & Capital Markets | 140 |
| 4 | Medical Devices & Healthcare Services | 93 |
| 5 | Retail & Consumer Services | 69 |
Regulatory Attention By Industry
Window
| # | Industry | Companies With Letters | Total Companies | Exposure Rate |
|---|---|---|---|---|
| 1 | Biotechnology | 204 | 774 | 26.4% |
| 2 | Medical Devices & Healthcare Services | 65 | 410 | 15.9% |
| 3 | Oil & Gas | 28 | 185 | 15.1% |
| 4 | Software & IT Services | 124 | 842 | 14.7% |
| 5 | Asset Management & Capital Markets | 84 | 626 | 13.4% |
Comment Letter Count By SEC Division
Window
| # | Division | Comment Letters | Latest Filing Date |
|---|---|---|---|
| 1 | Office of Life Sciences | 125 | Jan. 27, 2026 |
| 2 | Division of Corporation Finance | 85 | Jan. 13, 2026 |
| 3 | Office of Real Estate & Construction | 64 | Sep. 30, 2025 |
| 4 | Office of Trade & Services | 63 | Jan. 16, 2026 |
| 5 | Office of Technology | 52 | Dec. 30, 2025 |
| 6 | Office of Energy & Transportation | 43 | Jan. 13, 2026 |
| 7 | Office of Finance | 38 | Dec. 30, 2025 |
| 8 | Office of Industrial Applications and Services | 38 | Dec. 30, 2025 |
| 9 | Division of Corporation Finance Office of Life Sciences | 34 | Jan. 16, 2026 |
| 10 | Division of Corporation Finance Office of Manufacturing | 23 | Nov. 19, 2025 |
Each correspondence thread in SecProbe.io links SEC Comment Letters and Company Responses into a single timeline, with filing-level details available from one click.